Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation??

By Caserta Donatella   Lisi Franco   Marci Roberto   Ciardo Francesca   Fazi Alessandra   Lisi Roberta   Moscarini Massimo  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 862-866

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation

By Tiboni Gian Mario   Palumbo Paola   Leonzio Emiliana   Gabriele Elisabetta   Verna Ilde   Giampietro Franca  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite

Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation

By Noci I  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 531-534

Oxford University Press

Access to resources Recommend Favorite

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone

By Fleming R  

Human Reproduction, Vol. 13, Iss. 7, 1998-07 ,pp. : 1788-1792

Oxford University Press

Access to resources Recommend Favorite

Anti-Müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF

By Yates A.P.   Rustamov O.   Roberts S.A.   Lim H.Y.N.   Pemberton P.W.   Smith A.   Nardo L.G.  

Human Reproduction, Vol. 26, Iss. 9, 2011-09 ,pp. : 2353-2362

Oxford University Press

Access to resources Recommend Favorite